These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 10952326)

  • 1. Transfusion-associated graft-versus-host disease with transfusion practice in cardiac surgery.
    Yasuura K; Okamoto H; Matsuura A
    J Cardiovasc Surg (Torino); 2000 Jun; 41(3):377-80. PubMed ID: 10952326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two cases of transfusion-associated graft-vs-host disease after open heart surgery.
    Tanaka K; Aki T; Shulman HM; Sullivan KM; Tanaka A; Nagasako R
    Arch Dermatol; 1992 Nov; 128(11):1503-6. PubMed ID: 1444505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of 66 patients definitive with transfusion-associated graft-versus-host disease and the effect of universal irradiation of blood.
    Uchida S; Tadokoro K; Takahashi M; Yahagi H; Satake M; Juji T
    Transfus Med; 2013 Dec; 23(6):416-22. PubMed ID: 24274074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal transfusion-associated graft-versus-host disease with concomitant immune hemolysis in a group A combat trauma patient resuscitated with group O fresh whole blood.
    Gilstad C; Roschewski M; Wells J; Delmas A; Lackey J; Uribe P; Popa C; Jardeleza T; Roop S
    Transfusion; 2012 May; 52(5):930-5. PubMed ID: 21981662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease.
    Williamson LM; Stainsby D; Jones H; Love E; Chapman CE; Navarrete C; Lucas G; Beatty C; Casbard A; Cohen H
    Transfusion; 2007 Aug; 47(8):1455-67. PubMed ID: 17655590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion-associated graft versus host disease in the immunocompetent patient: an ongoing problem.
    Jawa RS; Young DH; Stothert JC; Kulaylat MN; Landmark JD
    J Intensive Care Med; 2015 Mar; 30(3):123-30. PubMed ID: 23792801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of transfusion-associated graft-vs.-host disease: the importance of short tandem repeat analysis.
    Sage D; Stanworth S; Turner D; Navarrete C
    Transfus Med; 2005 Dec; 15(6):481-5. PubMed ID: 16359419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
    Shivdasani RA; Anderson KC
    Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [One-way matching of HLA antigens between recipient and donor as a risk factor of transfusion-associated GVHD].
    Takahashi K
    Nihon Rinsho; 1997 Sep; 55(9):2240-5. PubMed ID: 9301283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transfusion-associated graft-vs-host disease].
    Lillevang ST; Kristensen T
    Ugeskr Laeger; 1992 Oct; 154(43):2964-8. PubMed ID: 1462384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature.
    Agbaht K; Altintas ND; Topeli A; Gokoz O; Ozcebe O
    Transfusion; 2007 Aug; 47(8):1405-11. PubMed ID: 17655584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors.
    Petz LD; Calhoun L; Yam P; Cecka M; Schiller G; Faitlowicz AR; Herron R; Sayah D; Wallace RB; Belldegrun A
    Transfusion; 1993 Sep; 33(9):742-50. PubMed ID: 8105567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Institution and significance of the new guidelines for prevention of transfusion associated graft versus host disease].
    Asai T
    Nihon Rinsho; 1997 Sep; 55(9):2296-304. PubMed ID: 9301293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of transfusion-associated graft-versus-host disease.
    Yasuda H; Ohto H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):69-75. PubMed ID: 7927137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors.
    Benson K; Marks AR; Marshall MJ; Goldstein JD
    Transfusion; 1994 May; 34(5):432-7. PubMed ID: 8191569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential for transfusion-associated graft-versus-host disease due to apheresis platelets matched for HLA class I antigens.
    Grishaber JE; Birney SM; Strauss RG
    Transfusion; 1993; 33(11):910-4. PubMed ID: 8259596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion-associated graft-versus-host disease.
    Sunul H; Erguven N
    Transfus Apher Sci; 2013 Oct; 49(2):331-3. PubMed ID: 23890576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-associated graft-versus-host disease: an overview and two case reports.
    Spector D
    Oncol Nurs Forum; 1995; 22(1):97-101. PubMed ID: 7708528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transfusion-associated graft-vs-host disease in a patient with Hodgkin's disease].
    Lillevang ST; Andersen CB; Schmidt KG; Riisom K
    Ugeskr Laeger; 1992 Oct; 154(43):2979-80. PubMed ID: 1462387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting.
    Ahya R; Douglas JG; Watson HG
    Heart; 1998 Sep; 80(3):299-300. PubMed ID: 9875094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.